Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Pfizer
Pfizer
Eli Lilly and Company
Prestige Biopharma Limited
Samsung Bioepis Co., Ltd.
Genentech, Inc.
Genentech, Inc.
Pharmatech
Mateon Therapeutics